Screening for PPAR Responsive Regulatory Modules in Cancer
Figure 3
A gene module map compiled from bioinformatics data and experimental datasets. The superimposition of the PPRE track (in green on top) on
other genome-wide datasets can reveal promising PPRE-containing binding modules
for targeted therapy via PPAR activation. In this imaginary setting,
transcription factor 1 (in blue) is known to be one main regulator of the
hypothetical gene X and this regulation is altered in cancer. Transcription
factor 2 (in yellow) synergistically activates gene X, but is lost in cancer
cells. Chromatin immunoprecipitation data comparing normal and cancer binding
profiles for this transcription factor reveal two main regulatory modules under
normal conditions and a weaker binding in cancer samples due to loss of
transcription factor 2. A colocalizing PPRE in module 2 could enable PPARs to
replace transcription factor 2 in this module and to restore strong activation
of this gene.